Bayesian Capital Management’s Labcorp LH Stock Holding History

Bayesian Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,300	Closed	-$2.1M	–	354
2025 Q3	$2.1M	Buy	+7,300	New	+$1.96M	0.43%	66
2022 Q4	–	Sell	-6,053	Closed	-$1.06M	–	916
2022 Q3	$1.06M	Sell	6,053 -2,328	-28%	-$477K	0.22%	128
2022 Q2	$1.69M	Buy	8,381 +6,751	+414%	+$1.44M	0.31%	71
2022 Q1	$369K	Buy	1,630 +729	+81%	+$171K	0.06%	463
2021 Q4	$243K	Sell	901 -1,194	-57%	-$296K	0.08%	288
2021 Q3	$507K	Buy	+2,095	New	+$528K	0.15%	187
2021 Q2	–	Sell	-1,241	Closed	-$272K	–	539
2021 Q1	$272K	Buy	+1,241	New	+$249K	0.06%	372
2019 Q2	–	Sell	-2,910	Closed	-$382K	–	607
2019 Q1	$382K	Buy	+2,910	New	+$358K	0.07%	351
2017 Q4	–	Sell	-17,111	Closed	-$2.22M	–	642
2017 Q3	$2.22M	Buy	+17,111	New	+$2.28M	0.53%	37
2016 Q3	–	Sell	-5,396	Closed	-$604K	–	441
2016 Q2	$604K	Buy	+5,396	New	+$581K	0.36%	86

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bayesian Capital Management's LH Position: Q4 2025 in Review

Bayesian Capital Management sold out of Labcorp (LH) in Q4 2025, closing a stake of 7,300 shares — an estimated $2.1M sold.

Bayesian Capital Management first reported a position in LH in Q2 2016 and held it in 10 quarters. The position peaked at $2.22M in Q3 2017. 1,027 funds tracked by Wall St. Rank hold LH as of Q4 2025.

Bayesian Capital Management reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
Bayesian Capital Management sold 7,300 Labcorp shares in Q4 2025, an estimated $2.1M.
Bayesian Capital Management first reported a position in Labcorp in Q2 2016 and held it in 10 quarters.
Bayesian Capital Management's Labcorp position peaked at $2.22M in Q3 2017.
1,027 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.